Home » EISAI FORMS ALLIANCE WITH SWEDISH FIRM FOR ALZHEIMER DRUG RESEARCH
EISAI FORMS ALLIANCE WITH SWEDISH FIRM FOR ALZHEIMER DRUG RESEARCH
Major drug maker Eisai Co. said Friday it has formed a strategic alliance with a Swedish bio venture to develop immunotherapy for Alzheimer's disease. The deal will give Eisai the preferential right to use BioArctic Neuroscience Inc.'s research results on Alzheimer's disease, the Tokyo-based firm said. Eisai has been actively forming alliances with outside entities to expand its product line-up in the neurology area.
Yahoo News (http://asia.news.yahoo.com/050826/kyodo/d8c7d8ko0.html)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May